Related references
Note: Only part of the references are listed.Amelioration of collagen-induced arthritis in mice by a novel phosphodiesterase 7 and 4 dual inhibitor, YM-393059
Satoshi Yamamoto et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Phosphodiesterase (PDE) 7 in inflammatory cells from patients with asthma and COPD
N. A. Jones et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2007)
Design of second generation phosphodiesterase 5 inhibitors
Michael J. Palmer et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2007)
22π smaragdyrin molecular conjugates with aromatic phenylacetylenes and ferrocenes:: Syntheses, electrochemical, and photonic properties
Rajneesh Misra et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2006)
Phosphodiesterase genes are associated with susceptibility to major depression and antidepressant treatment response
Ma-Li Wong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Phosphodiesterases in the CNS: targets for drug development
Frank S. Menniti et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Phosphodiesterase inhibitors in airways disease
KF Chung
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
Phosphodiesterase 7 (PDE7) as a therapeutic target
Mark A. Giembycz et al.
DRUGS OF THE FUTURE (2006)
Phosphodiesterase 7A: A new therapeutic target for alleviating chronic inflammation?
M. A. Giembycz et al.
CURRENT PHARMACEUTICAL DESIGN (2006)
Cyclic nucleotide phosphodiesterases: Molecular regulation to clinical use
Andrew T. Bender et al.
PHARMACOLOGICAL REVIEWS (2006)
Multiple elements jointly determine inhibitor selectivity of cyclic nucleotide phosphodiesterases 4 and 7
HC Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Phosphodiesterase: overview of protein structures, potential therapeutic applications and recent progress in drug development
YH Jeon et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2005)
The next generation of phosphodiesterase inhibitors: Structural clues to ligand and substrate selectivity of phosphodiesterases
DT Manallack et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Cyclic nucleotide phosphodiesterases and their role in immunomodulatory responses: Advances in the development of specific phosphodiesterase inhibitors
A Castro et al.
MEDICINAL RESEARCH REVIEWS (2005)
Evaluation of docking performance: Comparative data on docking algorithms
M Kontoyianni et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Discovery of thiadiazoles as a novel structural class of potent and selective PDE7 inhibitors. Part 1: Design, synthesis and structure-activity relationship studies
F Vergne et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2004)
Discovery of thiadiazoles as a novel structural class of potent and selective PDE7 inhibitors. Part 2: Metabolism-directed optimization studies towards orally bioavailable derivatives
F Vergne et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2004)
Spiroquinazolinones as novel, potent, and selective PDE7 inhibitors. Part 2: Optimization of 5,8-disubstituted derivatives
P Bernardelli et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2004)
Spiroquinazolinones as novel, potent, and selective PDE7 inhibitors. Part 1
E Lorthiois et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2004)
A glutamine switch mechanism for nucleotide selectivity by phosphodiesterases
KYJ Zhang et al.
MOLECULAR CELL (2004)
Identification of purine inhibitors of phosphodiesterase 7 (PDE7)
WJ Pitts et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2004)
Comparative evaluation of eight docking tools for docking and virtual screening accuracy
E Kellenberger et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2004)
Effects of Heterocyclic aromatic substituents on binding affinities at two distinct sites of somatostatin receptors. Correlation with the electrostatic potential of the substituents
V Prasad et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Do structurally similar molecules have similar biological activity?
YC Martin et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Potential role of phosphodiesterase 7 in human T cell function: comparative effects of two phosphodiesterase inhibitors
A Nakata et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2002)
Differential distribution of cAMP-specific phosphodiesterase 7A mRNA in rat brain and peripheral organs
X Miró et al.
SYNAPSE (2001)
Synthesis and structure-activity relationships of guan analogues as phosphodiesterase 7 (PDE7) inhibitors
MJ Barnes et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2001)
Benzyl derivatives of 2,1,3-benzo- and benzothieno[3,2-a]thiadiazine 2,2-dioxides:: First phosphodiesterase 7 inhibitors
A Martínez et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
Molecular cloning and characterization of a distinct human phosphodiesterase gene family: PDE11A
L Fawcett et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
